NCT01654016View on ClinicalTrials.gov

Study of Antiinflammatory Effects of Detralex (Daflon)

PHASE4CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2019

Study Completion Date

September 30, 2019

Conditions
Chronic Venous Insufficiency
Interventions
DRUG

Detralex

Detralex 500 mg twice daily for three month prior to surgery

Trial Locations (1)

10000

University Hospital Dubrava, Zagreb

All Listed Sponsors
collaborator

Servier

INDUSTRY

lead

University Hospital Dubrava

OTHER

NCT01654016 - Study of Antiinflammatory Effects of Detralex (Daflon) | Biotech Hunter | Biotech Hunter